Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Magnetic Tides has developed a novel non-invasive brain stimulation technology, kTMP, which combines the advantages of existing NIBS methods while overcoming their limitations. The prototype device has shown promising results in healthy volunteers and is approved as a Non-Significant Risk device for research. The company is progressing toward clinical validation for neurological and psychiatric indications with NIH funding support.[4][6]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Magnetic Tides.